Perioperative Application of Omega-3 Polyunsaturated Fatty Acids in Gastric Cancer Patients

• Status: Unknown status
• Trial end date: 2014-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate immunomodulatory effects of perioperative application of omega-3 polyunsaturated fatty acids in gastric cancer surgery, the effects of postoperative recovery, the improvement of nutritional status, incidence rate of related complications, and whether it can reduce the average postoperative hospitalization days.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jian Suo

Criteria

Inclusion Criteria:

• Patients coming to FirstJilinU diagnosed gastric cancer by endoscopy and pathology.

• No preoperative treatment, the gastric cancer radical surgery in our hospital is the first treatment.

• Nutrition screening score (NRS 3 or higher).

• Albumin and (or) immune enhancer were not used within two weeks before operation .

• No blood system diseases.

Exclusion Criteria:

• Being in the acute phase of inflammation before operation and emergency surgery.

• Patients combined metabolic diseases such as diabetes, hyperthyroidism, immune system disease or taking immunosuppressants;

• Combined hepatic insufficiency.

• Spleen resected in operation